You are currently viewing a new version of our website. To view the old version click .

Transcriptomes and Proteomes of Marine Venomous Animals as Source for Drug Discovery

Special Issue Information

Dear Colleagues,

Venomics integrates high-throughput proteomics, transcriptomics, and genomics to accelerate the large-scale study of venoms of peptidic nature and the discovery of novel therapeutic drugs. Every venomous marine species produces a unique cocktail, whose protein components can be characterized in detail using high-throughput techniques. By comparing gene family contents, expressed transcripts, and functional (post-translationally modified) protein products, it is possible to elucidate the different molecular mechanisms responsible for producing the great diversity of venoms. By comparing venom mixtures within a phylogenetic framework, it is also possible to distinguish those components that are shared between species (and determine whether they are derived from a common ancestor or convergent) from those that are evolutionary innovations of a particular taxon.

This Special Issue of Marine Drugs aims at gathering original research articles that contribute to catalogue the existing great diversity of marine venoms, and to understand how this diversity is generated and evolves. Attention is focused on the use of combined transcriptomic and proteomic tools to reach this ultimate goal.

Prof. Dr. Rafael Zardoya
Prof. Dr. Manuel Jiménez-Tenorio
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • trancriptomics
  • proteomics
  • evolution
  • venoms
  • drug discovery
  • mass spectrometry
  • next-generation sequencing

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Mar. Drugs - ISSN 1660-3397